Pharma & Bio
Lifestyle
KOSDAQ Newcomer Remedy Jumps 67% During Trading Session; HLB INC. Hits Lower Circuit Breaker for Second Consecutive Day... LEMON COMPANY LIMITED Also Plummets [Bio Spotlight]
Remedy and HLB INC., both making their KOSDAQ debuts, saw mixed fortunes. Remedy surged nearly double its initial public offering (IPO) price during the trading session, fueling expectations of a “fir…
Lifestyle
Remedi Surges, HLB Hits Limit Down as FDA Setback Weighs[K-Bio Pulse]
The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi emerging as the day’s standout performer, while HLB extended its selloff following another setback fro…
Lifestyle
Jeon Tae-yeon, CEO of Alteogen: “Samsung Bioepis Patent Covers Process Technology, Not the Substance… No Impact on ALT-B4”
“Based on the patents currently disclosed, it is difficult to conclude that Samsung Bioepis has secured a new substance to replace ALT-B4. Therefore, I do not believe this will have a direct impact on…
Lifestyle
[Exclusive] Samsung Epics' SC Patent Lacks Inventive Step... Also Differs from 'Huons Co., Ltd. and Alteogen Inc.' Technologies
It has been confirmed that the patent technology related to a subcutaneous (SC) injection formulation filed by Samsung Bioepis was not recognized as novel or inventive during the publication stage of …
Lifestyle
"More Than 10 CDAs Expected to Be Signed"... BL Pharmtech Accelerates Follow-Up Deals After Bio USA
"Based on current developments, we expect more than 10 confidentiality agreements (CDAs) to be signed."These are the words of Jeong Gwang-ho, Chief Technology Officer (CTO) of BL Pharmtech.
Jeong G…
Lifestyle
Out of 18 Listed Advertising Agencies, Only One Meets All Three Criteria: "Growth, Profitability, and High Margins" [In-Depth Analysis of Wise birds Inc.] (Part 2)
As companies tighten their marketing budgets in the wake of an overall economic slowdown, the advertising industry is facing a deepening winter. Typically, the fourth quarter—which reflects the year-e…
Technology
Choi Jeong-yun, CEO of HealthyMed: “To Combat Drugs… We’ve Entered an Era Where Early Prevention and Detection Must Become Mainstream”
Choi Jeong-yun, CEO of HealthyMed. (Photo courtesy of HealthyMed)
“While treatment and rehabilitation are important, prevention and early detection must come first to prevent even greater social c…
Technology
BreezeBio Passes Regulatory Review; What Makes Its Delivery Platform—Chosen by Genentech—So Competitive?
U.S.-based gene therapy delivery platform company BreezeBio (formerly GeneEdit) has passed the technology evaluation required for a KOSDAQ listing under the technology exception track and has official…
Lifestyle
[Exclusive] Remedy is the only company to pass the technical evaluation for a portable X-ray tender in Odisha, India... ‘Likely to Win the Contract’
#Remedy, a company specializing in X-ray technology, has secured an exclusive contract opportunity in India’s massive public healthcare procurement market—which serves a population of 1.4 billion—afte…
Lifestyle
Weeding Out the Good from the Bad in the Wake of the Peptron, Inc. Shock... Why G2GBIO, Inc. Is Being Reevaluated
The so-called “Peptron, Inc. incident” appears to be reshaping the investment landscape in South Korea’s microsphere-based long-acting drug delivery platform market. While the potential for joint rese…